Who is sponsoring NCT03895125?

NCT03895125 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT03895125?

Interventions in NCT03895125: [year1] dual-task training with task priority strategy, [year2-3] dual-task training with internal and external focus.

What condition does NCT03895125 study?

NCT03895125 studies Parkinson Disease.

Is NCT03895125 still recruiting?

NCT03895125 is currently terminated. Last updated 13 February 2020.

Last reviewed 2020-02-13 · How we verify

NCT03895125

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Learning Effects of Attentional Strategy on Dual-task Walking in Patients With Parkinson's Disease: Behavioral Performance and Neural Plasticity

Terminated NA Last updated 13 February 2020

What this trial tests

NA trial testing [year1] dual-task training with task priority strategy in Parkinson Disease in 1 participant. Terminated before completion.

Timeline

7 March 2019

Primary endpoint
12 February 2020

12 February 2020

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	1
Start date	7 March 2019
Primary completion	12 February 2020
Estimated completion	12 February 2020
Sites	1 location across Taiwan

Drugs / interventions tested

[year1] dual-task training with task priority strategy
[year2-3] dual-task training with internal and external focus

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

National Taiwan University Hospital

Who can join

40 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

\[year1\] 1. To compare the effects of dual-task training with two different task priority instruction in people with Parkinson's disease and healthy controls on dual-task weight shifting performances. 2. Investigate the changes of brain activities and functional connectivity after dual-task training with different task priority instructions. \[year 2-3\] To investigate the learning effects of walking with internal/external focus on walking automaticity and brain plasticity in dual-task walking training for PD patients with/without freezing of gait.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Differentiation in theta and gamma activation in weight-shifting learning between people with parkinson's disease of different anxiety severities.
Hung YT, Wu RM, Huang CY. · · 2024 · PMID 38890205 · DOI 10.1007/s11357-024-01236-7

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03895125 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 13 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03895125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing